Diagnostic Products Archives

Cat #: 91010061

IdentiClone^® IGH Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 91010081

IdentiClone^® IGH Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 91020021

IdentiClone^® IGK Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 91020031

IdentiClone^® IGK Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 91030011

IdentiClone^® IGL Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92000011

IdentiClone^® TCRB + TCRG T-Cell Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92000021

IdentiClone^® TCRB + TCRG T-cell Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92050011

IdentiClone^® TCRB Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92050021

IdentiClone^® TCRB Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92060011

IdentiClone^® TCRD Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92060021

IdentiClone^® TCRD Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070021

IdentiClone^® TCRG Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070041

IdentiClone^® TCRG Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: S100001

IdentiClone^® RUO TCRG 2.0 Software

IdentiClone RUO TCRG 2.0 software is an Research Use Only (RUO) product specifically designed for the analysis of raw FSA files obtained from the ABI ...

View Product

Cat #: 92070101

IdentiClone^® T-cell Receptor Gamma Gene Rearrangement Assay 2.0 – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes and generate products that are unique in length and sequence...

View Product

Cat #: 92070111

IdentiClone^® T-cell Receptor Gamma Gene Rearrangement Assay 2.0 MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes and generate products that are unique in length and sequence...

View Product

Cat #: 40920010

IVS-0000 Polyclonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1 mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient...

View Product

Cat #: 40880010

IVS-0001 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40890100

IVS-0002 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0002 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40890190

IVS-0003 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0003 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40880190

IVS-0004 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40880370

IVS-0007 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40880430

IVS-0008 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40880490

IVS-0009 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40880550

IVS-0010 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40890910

IVS-0011 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0011 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40880730

IVS-0013 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40891270

IVS-0015 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0015 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40881090

IVS-0019 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40891720

IVS-0020 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0020 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40881210

IVS-0021 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficien...

View Product

Cat #: 40881390

IVS-0024 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/ml in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40881690

IVS-0029 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40881750

IVS-0030 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40881810

IVS-0031 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40892800

IVS-0032 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0032 Clonal Control RNA can be used as a posit...

View Product

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing